In studies related to RCC, researchers demonstrated that CD28 co‐stimulation significantly improved the glycolysis and mitochondrial metabolism of CD8+ TLs, thereby improving their mitochondrial and effector functions, possibly by upregulating GLUT3.107. This evidence concerns the gene CD8A and renal cell carcinoma.